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Abstract. 
 
Endocytosis of cell surface proteins is medi-
ated by a complex molecular machinery that assembles
on the inner surface of the plasma membrane. Here, we
report the identiﬁcation of two ubiquitously expressed
human proteins, stonin 1 and stonin 2, related to com-
ponents of the endocytic machinery. The human stonins
are homologous to the 
 
Drosophila melanogaster
 
 stoned
B protein and exhibit a modular structure consisting of
an NH
 
2
 
-terminal proline-rich domain, a central region
of homology speciﬁc to the stonins, and a COOH-ter-
minal region homologous to the 
 
 
 
 subunits of adaptor
protein (AP) complexes. Stonin 2, but not stonin 1, in-
teracts with the endocytic machinery proteins Eps15,
Eps15R, and intersectin 1. These interactions occur via
two NPF motifs in the proline-rich domain of stonin 2
and Eps15 homology domains of Eps15, Eps15R, and
intersectin 1. Stonin 2 also interacts indirectly with the
adaptor protein complex, AP-2. In addition, stonin 2
binds to the C2B domains of synaptotagmins I and II.
Overexpression of GFP–stonin 2 interferes with re-
cruitment of AP-2 to the plasma membrane and impairs
internalization of the transferrin, epidermal growth fac-
tor, and low density lipoprotein receptors. These obser-
vations suggest that stonin 2 is a novel component of
the general endocytic machinery.
Key words: receptor-mediated endocytosis • clathrin
• AP-2 • Eps15 • intersectin 
 
Introduction
 
The internalization of plasma membrane proteins is critical
to many important physiological processes such as synaptic
vesicle recycling and receptor-mediated endocytosis. These
processes are mediated by a complex molecular machinery
that is recruited from the cytosol to the inner surface of the
plasma membrane, where it assembles into a supramolecu-
lar structure known as a protein coat (for reviews see
Owen and Luzio, 2000; Kirchhausen, 2000; Slepnev and De
Camilli, 2000). The coat selects integral membrane pro-
teins destined for internalization and participates in the
formation of endocytic vesicles. The main structural con-
stituent of plasma membrane coats is the protein clathrin.
Assembly of clathrin coats onto the plasma membrane is
initiated by binding of the heterotetrameric adaptor pro-
tein (AP)
 
1
 
 complex, AP-2, to a member of the synaptotag-
min family of integral membrane proteins (Zhang et al.,
1994; Haucke et al., 2000). Clathrin triskelions then poly-
merize onto the membrane-bound AP-2 to form a lattice
that serves as a scaffold for the protein coat. Integral mem-
brane proteins containing either tyrosine-based or dileu-
cine-based endocytic signals are concentrated within the
assembling coats by interaction of these signals with AP-2
(for review see Bonifacino and Dell’Angelica, 1999; Heilker
et al., 1999). Various accessory proteins (e.g., amphiphysins,
Eps15, intersectins, dynamins, etc.) become associated with
the coat by either direct or indirect interaction with clathrin
and/or AP-2. These accessory proteins are thought to reg-
ulate coat assembly and vesicle budding, as well as interac-
tions of the endocytic machinery with signal transduction
pathways and the actin cytoskeleton (Kirchhausen, 2000;
Owen and Luzio, 2000; Slepnev and De Camilli, 2000).
Novel components of the machinery are still being iden-
tified through biochemical and genetic approaches. A par-
ticularly useful approach to identify physiologically critical
components of the endocytic machinery has been the study
of temperature-sensitive paralytic mutants of 
 
D
 
.
 
 melano-
gaster
 
 pioneered by David Suzuki and colleagues (Grigli-
atti et al., 1973). Some of these mutants bear defects in
genes involved in synaptic vesicle recycling from the
plasma membrane. Inactivation of these genes upon shift
to the nonpermissive temperature results in an inability to
reform synaptic vesicles after exocytosis. One of these mu-
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tant genes, 
 
shibire
 
, was found to encode a 
 
D
 
.
 
 melanogaster
 
homologue of mammalian dynamins (Chen et al., 1991; van
der Bliek and Meyerowitz, 1991). Another paralytic mu-
tant, 
 
stoned
 
, was found to bear mutations in a dicistronic
transcript encoding two structurally unrelated proteins, stoned
A and stoned B (Andrews et al., 1996). Although stoned
A has no homology to any other known protein, stoned B
comprises a COOH-terminal domain with homology to
the 
 
 
 
2 subunit of AP-2 (Andrews et al., 1996). Combina-
tion of hypomorphic 
 
shibire
 
 and 
 
stoned
 
 mutations produces
synthetic lethality, suggesting that the products of these
genes participate in either the same or parallel pathways of
synaptic vesicle biogenesis (Petrovich et al., 1993). It re-
mains to be established, however, whether the 
 
stoned
 
 gene
products play a role in endocytosis itself, and whether this
role is limited to neurons or general to all cells.
To investigate the possible involvement of 
 
stoned
 
 gene
products in endocytosis in a system that is more amenable
to biochemical and cellular analyses, we sought to identify
human homologues of these proteins. Here, we report the
identification and characterization of two ubiquitously ex-
pressed human homologues of the 
 
D
 
.
 
 melanogaster
 
 stoned
B protein named stonin 1 and stonin 2. The results of our
study suggest that stonin 2 is a component of the general
endocytic machinery in higher eukaryotes.
 
Materials and Methods
 
Cloning of Stonin 1 and Stonin 2 cDNAs
 
A search of DNA databases for human homologues of 
 
D
 
.
 
 melanogaster
 
stoned B identified the SALF protein (Upadhyaya et al., 1999) and a re-
lated fetal lung protein encoded by a novel cDNA sequence (GenBank/
EMBL/DDBJ accession no. AI734225). Primers corresponding to SALF
were used in 5
 
 
 
- and 3
 
 
 
-RACE PCR on a Marathon-Ready™ human heart
cDNA library (CLONTECH Laboratories, Inc.) to isolate a novel tran-
script, herein termed Stonin 1 (GenBank/EMBL/DDBJ accession no.
AF255310), encoding the NH
 
2
 
-terminal 711 of the 1,182–amino acid
SALF. The complete ORF of the second human cDNA, herein termed
Stonin 2 (GenBank/EMBL/DDBJ accession no. AF255309) was similarly
obtained from a Marathon-Ready™ human spleen cDNA library
(CLONTECH Laboratories, Inc.), using primers designed on the basis of
partial genomic DNA sequences (GenBank/EMBL/DDBJ accession nos.
AC010582 and AL136040). The identical stonin 1 and stonin 2 full-length
sequences were amplified by RT-PCR from mRNA of multiple human
cell lines (HeLa, Jurkat, 293T, and Caco-2A). The above PCR products
were cloned into the pCR2.1 vector (Invitrogen) and sequenced.
 
Northern Blotting
 
Northern blot analysis was performed on multiple human tissue blots
(CLONTECH Laboratories, Inc.) as described previously (Dell’Angelica et
al., 1997). Stonin 1 and stonin 2 cDNA probes were obtained by PCR. For
stonin 1, two different probes were used in separate experiments: the proline-
rich domain probe comprised nucleotides 1–615 and the 
 
 
 
-homology domain
probe comprised nucleotides 1187–2509 of the full-length stonin 1 cDNA.
The probe for stonin 2 corresponded to the complete coding sequence.
 
Antibodies
 
Polyclonal antibodies to human stonin 1 and stonin 2 were generated by
immunizing rabbits with the corresponding proline-rich domains fused to
a deca-histidine tag. The fusion proteins were recovered from inclusion
bodies by extraction in 6 M urea. A monoclonal antibody to human Eps15
and a polyclonal antibody to 
 
Xenopus
 
 intersectin were gifts from Dr. Pier
Paolo Di Fiore (European Institute of Oncology, Milan, Italy) and Dr. Pe-
ter McPherson (McGill University, Montreal, Canada), respectively. The
following monoclonal antibodies were also used: HA.11; to the hemagglu-
tinin epitope and 9E10; to the Myc epitope (Covance), 100/3; to 
 
 
 
1-adap-
tin and AP.6; to 
 
 
 
-adaptin (Sigma-Aldrich), clones 7.1 and 13.1; to the
green fluorescent protein (GFP; Roche Molecular Biochemicals) and
H4A3; to lamp-1 (Developmental Studies Hybridoma Bank). The follow-
ing polyclonal antibodies were also used: anti-GFP antiserum (Medical
and Biological Laboratories Co.) and serum anti–caveolin antiserum
(Transduction Laboratories).
 
Recombinant DNA Constructs
 
GFP fusion constructs, comprising the proline-rich domain of human sto-
nin 2, namely GFP–stonin 2
 
PRD
 
 (residues 1–223) and the full-length GFP–
stonin 2, were cloned into the pEGFP-C1 (HindIII-SmaI) vector (CLON-
TECH Laboratories, Inc.). The complete ORF of human stonin 1 was
fused to GFP by cloning into pEGFP-C2 (GFP–stonin 1, KpnI-BamHI).
Epitope-tagging at the NH
 
2
 
 terminus of stonin 2 was performed through
PCR amplification of the full-length stonin 2 cDNA using 5
 
 
 
-primer con-
taining the nucleotide sequence for the Myc epitope. This product was
cloned into the XhoI-XbaI sites of the mammalian expression vector pCI-
neo (Promega). The PRD 
 
  
 
SHD domains of stonin 2 were subcloned into
the XhoI-XmaI sites of the pCI-neo vector (Myc-stonin 2
 
PRD
 
 
 
SHD
 
; residues
1–359) using the same approach. Two-hybrid constructs in the pGBKT7
(TRP1) vector (CLONTECH Laboratories, Inc.) were prepared by clon-
ing of nucleotide sequences coding for the following amino acid residues:
1–296 of human Eps15 (Eps15–Eps15 homology (EH); NdeI-BamHI);
1–395 of human Eps15R (Eps15R-EH; EcoRI-BamHI); and 1–333 of human
intersectin 1 (intersectin 1-EH; NdeI-XmaI). Similarly, the stonin 1 (full-
length; XhoI-XmaI), stonin 2 (full-length; NdeI-XmaI), stonin 2
 
PRD
 
 
 
SHD
 
(NdeI-XmaI), and human epsin 2 (full-length; NdeI-EcoRI) cDNAs were
cloned into the pGADT7 (LEU2) vector (CLONTECH Laboratories,
Inc.) to obtain the corresponding GAL4 transcription activation domain
(GAL4ad) fusion constructs. The constructs (protein names and amino
acid numbers indicated in parentheses) glutathione 
 
S
 
-transferase (GST)–
intersectin 1-EH (intersectin 1, 1–333), GST–synaptotagmin I-C2AB (mu-
rine synaptotagmin I, 96–421), GST–synaptotagmin I-C2A (synaptotagmin
I, 96–265), GST–synaptotagmin I-C2B (synaptotagmin I, 248–421), GST–
synaptotagmin II-C2AB (murine synaptotagmin II, 124–422), GST–synap-
totagmin II-C2A (synaptotagmin II, 124–272), and GST–synaptotagmin II-
C2B (synaptotagmin II, 249–422) were cloned into the EcoRI-XhoI sites of
the pGEX-5X-1 vector (Amersham Pharmacia Biotech). GST–Eps15-EH
was generated by cloning of the cDNA sequence corresponding to residues
1–296 of Eps15 into the BamHI-XhoI sites of the pGEX-4T-1 vector (Am-
ersham Pharmacia Biotech). For protein expression and purification, com-
petent 
 
E
 
.
 
 coli
 
 strains DH5
 
 
 
 (PGC Scientific) or BL21 (DE3) (Novagen
Inc.) cells were transformed with the above constructs. Recombinant GST
fusion proteins were purified by using glutathione–Sepharose 4B beads
(Amersham Pharmacia Biotech), and amino acid substitutions in the pro-
line-rich domain of stonin 2 (N110A, P111A, F112A, P127A, and F128A)
were made using the QuickChange mutagenesis kit (Stratagene), accord-
ing to the manufacturer’s instructions.
 
Transfection, Immunofluorescence, 
and Internalization Assays
 
The sources and culture conditions for all the human cell lines used in this
study are described elsewhere (Dell’Angelica et al., 1997). Human HeLa
or M1 cells, grown on glass coverslips, were transfected by using Fu-
GENE-6 (Roche Molecular Biochemicals). Cells were incubated with 7
mM Na-butyrate for 12 h before fixation. At 24 h after transfection, cells
were either fixed and processed for immunofluorescence (Dell’Angelica
et al., 1997) or used directly for analysis of rhodamine-EGF (500 ng/ml),
Dil-LDL (10 ng/
 
 
 
l), or Cy3-transferrin (530 ng/ml) internalization (Ben-
merah et al., 2000; Cy3-transferrin was a gift from Timothy McGraw,
Weill Medical College, New York, NY). The internalization of
rhodamine-EGF was performed using the same conditions as for Cy3-
transferrin, with the exception that the serum starvation was much longer
(12 h) and was done in the presence of 0.5% (vol/vol) serum. Images were
acquired on an LSM 410 confocal microscope (Carl Zeiss, Inc.).
 
General Biochemical Procedures
 
Metabolic labeling of cells in culture with [
 
35
 
S]methionine, preparation of
Triton X-100, detergent-free extracts of post-nuclear membranes, ultra-
centrifugation on sucrose gradients, and immunoprecipitation–recapture
were carried out as described (Dell’Angelica et al., 1997). For cell frac-
tionation, [
 
35
 
S]methionine-labeled cells were disrupted in lysis buffer (10
mM Tris-HCl, pH 7.4, 250 mM sucrose with a cocktail of protease inhibi- 
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tors) (Dell’Angelica et al., 1997) by 20 passages through a 25-gauge needle
on ice. Samples were centrifuged at 500 
 
g
 
 for 10 min at 4
 
 
 
C, and the result-
ing supernatants (postnuclear supernatant) were subjected to ultracentrif-
ugation at 105,000 
 
g
 
 for 1 h at 4
 
 
 
C to obtain cytosolic (supernatant) and
membrane (pellet) fractions. For extraction experiments, the membrane
fraction was resuspended in lysis buffer and divided into six equal ali-
quots. Aliquots were then incubated for 45 min at 4
 
 
 
C in lysis buffer con-
taining either 1 M Tris-HCl (pH 7.4), 1 M NaCl, 0.2 M Na
 
2
 
CO
 
3
 
 (pH 11.3),
1.6 M urea, 2% (wt/vol) Triton X-100, or left untreated. After the incuba-
tion period, samples were centrifuged at 105,000 
 
g
 
 for 1 h, and both pellets
and supernatants were collected for further analysis. To obtain a fraction
enriched in detergent-resistant membranes, cellular extracts were sub-
jected to a discontinuous sucrose gradient as described (Ilangumaran and
Hoessli, 1998), with the exception that 0.9-ml fractions were collected
from the top of the gradient. Then, 0.5 ml of each fraction was diluted 1:1
in immunoprecipitation buffer and used for immunoprecipitation–recap-
ture with the antibodies described in the corresponding figure legend. For
in vitro translation of Myc-stonin 2
 
PRD
 
 
 
SHD
 
, [
 
35
 
S]methionine-labeled pro-
teins were synthesized in vitro using the TNT
 
®
 
 Coupled Reticulocyte Ly-
sate System (Promega). Postribosomal supernatants were then generated
by centrifugation at 200,000 
 
g
 
 and used for GST pull-down assays.
 
GST Pull-down Assays
 
15 
 
 
 
g of either GST–Eps15-EH or GST–intersectin 1-EH fusion proteins im-
mobilized on glutathione–Sepharose were incubated with in vitro translation
products or extracts from transfected HeLa cells (0.8 mg of protein) in bind-
ing buffer (25 mM Tris-HCl, pH 7.5, 100 mM NaCl, 5 mM MgCl
 
2
 
, 1 mM
EDTA, protease inhibitors, and 1% [wt/vol] Triton X-100) for 4 h at 4°C. 20
 
 
 
g of GST–synaptotagmin fusion proteins were incubated as described
above, with the exception that the binding buffer used was 50 mM Hepes (pH
7.4), 100 mM NaCl, 1 mM MgCl
 
2
 
, protease inhibitors, and 1% (wt/vol) Triton
X-100. Beads were spun and washed four times with ice-cold binding buffer
and once with ice-cold binding buffer lacking detergent. Bound proteins were
analyzed either by immunoblotting or immunoprecipitation–recapture fol-
lowed by SDS-PAGE and fluorography. For all experiments, GST alone and
GST–GGA3-GAE (for nonspecific binding) were used as controls.
 
Yeast Culture, Transformation, and Two-Hybrid Assays
 
The 
 
S
 
.
 
 cerevisiae
 
 strain AH109 (CLONTECH Laboratories, Inc.) was
transformed by the lithium acetate procedure as described in the instruc-
tions for the MATCHMAKER two-hybrid kit (CLONTECH Laborato-
ries, Inc.). For colony growth assays, AH109 transformants were resus-
pended in water to 0.1 OD
 
600
 
/ml, and then 5 
 
 
 
l was spotted on plates
lacking leucine, tryptophan, and histidine in the presence or absence of
adenine, and containing 10 mM 3-amino-1,2,4-triazole (Fluka Chemie
AG) and incubated at 30
 
 
 
C for 4–5 d.
 
Results
 
Identification of Human Stonin 1 and Stonin 2
 
Two distinct human transcripts encoding homologues of
the 
 
D
 
.
 
 melanogaster
 
 stoned B protein were identified
through searches of GenBank. The complete ORFs for
these proteins, herein referred to as stonin 1 and stonin 2,
were obtained by a combination of 5
 
 
 
 and 3
 
 
 
 RACE and
PCR amplification. Unlike the 
 
D
 
.
 
 melanogaster
 
 
 
stoned
 
transcripts, the human stonin transcripts were monocis-
tronic and did not encode stoned A–related products. In
fact, our searches did not turn up homologues of 
 
D
 
.
 
 mela-
nogaster
 
 stoned A in any other organism. The human sto-
nin 1 transcript encodes a protein of 735 amino acids and a
predicted molecular mass of 
 
 
 
83 kD, whereas the stonin 2
transcript encodes a protein of 702 amino acids and a pre-
dicted molecular mass of 
 
 
 
79 kD. Residues 1–711 of sto-
nin 1 are almost identical to residues 1–711 of the 1,182–
amino acid product of the SALF transcript (Upadhyaya et
al., 1999). This transcript has been proposed to encode a
protein with an NH
 
2
 
-terminal region homologous to the
 
D
 
.
 
 melanogaster
 
 stoned B protein and a COOH- terminal
region homologous to the general transcription factor
TFIIA
 
 
 
/
 
 
 
 (Upadhyaya et al., 1999). It has been suggested
that SALF is a product of two separate but adjacent hu-
man genes, which is formed from a pre-mRNA transcript
that initiates at an upstream Stoned B–like factor gene and
continues into the ALF gene (Han et al., 2001). The stonin
1 transcript reported here differs from the SALF tran-
script in that it has an inframe termination codon after the
stonin 1 sequence and does not contain the TFIIA
 
 
 
/
 
 
 
–
homologous sequence. The existence of the stonin 1 tran-
script was confirmed by RT-PCR from total RNA of mul-
tiple cell lines and by PCR amplification from human
heart and spleen libraries. Orthologues of both human sto-
nin 1 and stonin 2 were found in the mouse (Martina, J.A.,
and J.S. Bonifacino, unpublished observations). Single
homologues of these proteins exist in 
 
D
 
.
 
 melanogaster
 
(i.e., stoned B) and 
 
C
 
.
 
 elegans
 
 (i.e., hypothetical protein
C27H6.1), but none in yeast and prokaryotes.
 
Domain Organization of Human Stonin 1 and Stonin 2
 
The two human stonins, as well as their 
 
D
 
.
 
 melanogaster
 
and 
 
C
 
.
 
 elegans
 
 counterparts, exhibit a modular structure
consisting of an NH
 
2
 
-terminal proline- and serine-rich do-
main (herein referred to as proline-rich domain), a central
domain specific to the stonins (stonin homology domain),
and a COOH-terminal domain homologous to the signal-
binding domain of the 
 
 
 
 subunits of AP complexes (
 
 
 
-
homology domain) (Fig. 1 A). The proline-rich domains of
the human, 
 
D
 
.
 
 melanogaster
 
, and 
 
C
 
.
 
 elegans
 
 homologues are
of variable length and exhibit little or no significant sequence
homology to one another, except for the abundance of pro-
line and serine residues. The proline-rich domain of 
 
D
 
.
 
 mela-
nogaster
 
 stoned B displays seven NPF motifs (Andrews et
al., 1996; Stimson et al., 1998), which in general have been
shown to mediate interactions with Eps15 homology (EH)
domains (Salcini et al., 1997). Despite the lack of overall
homology in this region, the proline-rich domain of stonin
2, but not that of stonin 1, has two NPF motifs separated by
13 amino acids (Fig. 1 B). A similar arrangement of NPF
motifs is found in epsin 1 and epsin 2 (Fig. 1 B) (Chen et al.,
1998; Yamabhai et al., 1998; Hussain et al., 1999; Rosenthal
et al., 1999). Not only are the NPF motifs in stonin 2 and the
epsins similarly spaced but they also flank an intervening
sequence containing additional conserved residues. Most
notable is the presence of an L residue after the first NPF
motif, a feature that has been shown to enhance interaction
with certain EH domains (de Beer et al., 2000). Another
short stretch of amino acids in the proline-rich domain of
stonin 2 is highly similar to a stretch in the proline-rich re-
gion of amphiphysin 2 (Fig. 1 B) (Leprince et al., 1997;
Ramjaun et al., 1997; Wigge et al., 1997).
Next to the proline-rich domain lies an 
 
 
 
140–amino acid
domain (stonin homology domain) that is conserved in both
human stonins, as well as their 
 
D
 
.
 
 melanogaster
 
 and 
 
C
 
.
 
 ele-
gans
 
 homologues (Fig. 1, A and C). This domain has not
been described in other proteins and may thus be unique to
members of the stonin family. Immediately adjacent to this
domain in all stonin homologues is an 
 
 
 
350–amino acid do-
main homologous to the YXXØ signal-binding domain of
 
 
 
2 (Aguilar et al., 1997; Owen and Evans, 1998), a subunit of
the heterotetrameric AP-2 complex (Fig. 1, A and C). A 
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similar domain is found in the related 
 
 
 
1 (A and B iso-
forms), 
 
 
 
3 (A and B isoforms), and 
 
 
 
4 subunits of the het-
erotetrameric AP complexes, AP-1, AP-3, and AP-4, respec-
tively (for review see Hirst and Robinson, 1998; Bonifacino
and Dell’Angelica, 1999). These theoretical analyses thus in-
dicate that the stonins share several structural features with
known components of the sorting machinery.
 
Ubiquitous Expression of Human Stonin 1 and Stonin2
 
Because mutations in the 
 
D
 
.
 
 melanogaster
 
 
 
stoned
 
 locus re-
sult in severe neurological dysfunction (Petrovich et al.,
1993; Andrews et al., 1996; Fergestad et al., 1999), it was of
interest to determine the pattern of tissue and cell expres-
sion of the human stonins. Northern blot analysis revealed
expression of a 6.5-kb stonin 1 mRNA and a 11.3-kb sto-
nin 2 mRNA in most human tissues examined (Fig. 2 A).
To study expression of the corresponding proteins, we
raised polyclonal antibodies to their proline-rich domains.
These antibodies were used to identify the proteins by im-
munoprecipitation–recapture from metabolically labeled
cells (Bonifacino and Dell’Angelica, 1998). The antibodies
to stonin 1 and stonin 2 were found to immunoprecipitate
major species of 
 
 
 
81 and 
 
 88 kD, respectively, in reason-
able agreement with their predicted molecular weights
(Fig. 2 B). The bands detected by these antibodies were
specific, as they were not detected using preimmune sera
(PI) or antisera absorbed with the corresponding immuno-
gens (Fig. 2 B). Use of these antibodies allowed us to dem-
onstrate expression of both stonins in neuronal (H4) as
well as nonneuronal (RD4, M1, HeLa, and 293T) human
cells (Fig. 2 C). Thus, both stonins are ubiquitously ex-
pressed in human tissues, suggesting that their role might
not be restricted to the nervous system.
Both Human Stonins Exist as Cytosolic 
and Peripheral Membrane Proteins
Fractionation of metabolically labeled HeLa cells showed
that stonin 1 was mostly recovered in a cytosolic fraction
(C), with a small amount being associated with membranes
(M) (Fig. 3 A). Stonin 2 was present in equal amounts in
the cytosolic and membrane fractions (Fig. 3 A). The mem-
brane-bound stonin 1 and stonin 2 could be partially ex-
tracted with 1 M Tris or NaCl, and totally extracted with
0.2 M Na2CO3, pH 11.3 (Fig. 3 B), indicating that they be-
Figure 1. Structure of stonins and related pro-
teins. (A) Schematic representation of human
stonin 1 (Hs Stn1, GenBank/EMBL/DDBJ ac-
cession no. AF255310), human stonin 2 (Hs Stn2,
AF255309),  D.  melanogaster stoned B (Dm
STNB, U54982), C. elegans hypothetical protein
C27H6.1 (Ce C27H6.1, Z81042), and the human
 2 subunit of the AP-2 complex (Hs  2,
NM_004068). Specific domains of homology are
color coded and denoted as follows: PRD, pro-
line-rich domain; SHD, stonin homology domain;
MHD,  -homology domain; BBD,  -binding do-
main. Black lines denote regions with no signifi-
cant sequence homology. Numbers of NPF or
DPF motifs in the PRDs are indicated. (B)
Alignment of short sequences in the PRD of hu-
man stonin 2 with homologous sequences in
human (Hs) epsin 1 (AF073727), epsin 2
(AF062084), and amphiphysin 2 (AAB63263).
Identical residues are boxed, and NPF motifs are
highlighted in yellow. (C) Multiple sequence
alignment of the SHD and MHD domains of sto-
nin family members. The black and gray boxes
indicate identical and strongly conserved amino
acids, respectively. Blue and orange dots indicate
amino acids in  2 that are involved in binding
YXXØ-type signals (Owen and Evans, 1998)
and the C2B domain of synaptotagmin I
(Haucke et al., 2000), respectively. Numbers de-
noting the last amino acid in each sequence are
indicated on the right.Martina et al. Stonins and Endocytosis 1115
haved as peripheral membrane proteins. Interestingly, a large
fraction of both membrane-bound stonins remained insolu-
ble upon extraction with 2% (wt/vol) Triton X-100 at 4 C
(Fig. 3 B). This insoluble stonin 2, however, was not associ-
ated with detergent-resistant lipid domains, as determined
by its failure to float with caveolin-containing fractions in
sucrose density gradients (Fig. 3 C). Thus, the stonins ap-
pear to exist in cytosolic and peripheral membrane pools.
Human Stonins Are Not Subunits of AP Complexes
As mentioned above, the stonins contain a COOH-termi-
nal domain homologous to the YXXØ signal-binding do-
main of the   subunits of the heterotetrameric AP com-
plexes, AP-1, AP-2, AP-3, and AP-4 (Aguilar et al., 1997;
Owen and Evans, 1998). However, the stonins lack an-
other domain present in the   subunits that mediates as-
sembly with the   subunits of the corresponding AP com-
plexes ( -binding domain; Fig. 1 C, BBD) (Aguilar et al.,
1997). In agreement with this, we did not observe copre-
cipitation of stoichiometric amounts of either stonin 1 or
stonin 2 with subunits of any of the four AP complexes
(data not shown). Analysis of the cytosolic stonins by sedi-
mentation velocity analysis on sucrose gradients (Marks,
1998) revealed that both proteins sedimented as if they
were much smaller than a typical heterotetrameric AP
complex, AP-1 (sedimentation coefficient 7.7S, molecular
mass  270 kD) (Fig. 3 D). In fact, the size of both stonins
corresponded to that of monomers or small oligomers.
Interaction of Stonin 2 with the EH Domains of Eps15, 
Eps15R, and Intersectin 1 in the Yeast Two-Hybrid System
To gain insight into the possible function of the human sto-
nins, we sought to identify some of their binding partners.
The presence of two NPF motifs in the proline-rich domain
Figure 2. Expression of stonins in human tissues and cells. (A)
Northern blot analysis of the expression of stonin 1 (Stn1) and
stonin 2 (Stn2) mRNAs in human tissues. The positions of RNA
molecular size markers (in kb) are indicated on the left. (B) Im-
munoprecipitation–recapture of endogenous stonin 1 and stonin
2 proteins from [35S]methionine-labeled HeLa cells using preim-
mune serum (PI), specific antibodies to each protein, or specific
antibodies preabsorbed with the immunogens. Immunoprecipi-
tates were analyzed by 4–20% SDS-PAGE. The positions of pro-
tein molecular mass markers (in kD) are indicated on the left.
(C) Expression of endogenous stonin 1 and stonin 2 proteins in
different human cell lines. Stonins were isolated from equal
quantities of [35S]methionine-labeled cell lines using specific anti-
bodies to each protein, as in B.
Figure 3. Analysis of the association of stonins with mem-
branes. (A) Immunoprecipitation–recapture of stonin 1 (Stn1)
and stonin 2 (Stn2) from a postnuclear supernatant (PNS) of
[35S]methionine-labeled HeLa cells and from cytosolic (C) and
membrane (M) fractions of the PNS after ultracentrifugation. (B)
Membrane fractions obtained as in A were extracted for 45 min
at 4 C with the solutions indicated on top. Pellet (P) and superna-
tant (S) fractions were then prepared by ultracentrifugation, and
stonin 1, stonin 2, and lamp-1 were isolated by immunoprecipita-
tion–recapture with specific antibodies. (C) [35S]methionine-
labeled HeLa cells were solubilized in 2% (wt/vol) Triton X-100
on ice for 30 min, and the extract was centrifuged on a discontin-
uous sucrose gradient. Stonin 2, caveolin, the  1 subunit of AP-1
and lamp-1 were then isolated from the indicated gradient frac-
tions using specific antibodies. The positions of molecular mass
markers (in kD) are indicated on the left. (D) Analysis of the
size of stonins by sedimentation velocity. A cytosolic fraction of
[35S]methionine-labeled HeLa cells was separated by ultracen-
trifugation on a 4–20% sucrose gradient. Stonin 1, stonin 2, and
 1-adaptin (a marker for the position of cytosolic AP-1, 7.7S; Na-
kagawa et al., 2000) were isolated by immunoprecipitation–recap-
ture from gradient fractions.The Journal of Cell Biology, Volume 153, 2001 1116
of stonin 2 pointed to possible interactions with proteins
containing EH domains. Moreover, the existence of two
similarly spaced NPF motifs in epsin 1 and epsin 2, as well
as the conservation of additional amino acids in the inter-
vening sequence of these proteins, suggested that the EH-
containing binding partners could be shared with the epsins.
Both epsin 1 and epsin 2 have been shown to bind Eps15
and intersectin 1 via NPF–EH domain interactions (Chen et
al., 1998; Yamabhai et al., 1998; Hussain et al., 1999;
Rosenthal et al., 1999; Sengar et al., 1999). To examine if
the stonins also interact with these proteins, we performed
yeast two-hybrid analyses. GAL4 DNA binding domain
(GAL4bd) constructs encoding the three NH2-terminal EH
domains from Eps15 or the related Eps15R protein, or the
two NH2-terminal EH domains from intersectin 1 (re-
viewed in Di Fiore et al., 1997; Mayer, 1999), were coex-
pressed with GAL4ad constructs encoding stonin 1, stonin
2, or mutants of these proteins (Fig. 4 A). Stonin 1 did not
interact with any of the EH domain constructs, as expected
from the absence of NPF motifs in this protein (Fig. 4 A).
Stonin 2, on the other hand, interacted with the EH do-
mains of Eps15 and Eps15R, and more weakly with those of
intersectin 1 (Fig. 4 A). Deletion of the  -homology domain
from stonin 2 enhanced growth of the cotransformants (Fig.
4 A, Stn2PRD SHD), probably due to increased expression of
the truncated protein (data not shown). Mutation of the
first NPF motif to either NAA or APA in the context of
the stonin 2PRD SHD construct decreased interactions with
the EH domains of Eps15 and Eps15R and completely ab-
rogated interactions with the EH domains of intersectin 1.
Mutation of the second NPF motif to NAA, on the other
hand, had little effect on the interactions. Finally, mutation
of both NPF motifs to NAA completely abolished interac-
tions with all EH domains (Fig. 4 A). All the positive and
negative controls yielded the expected results, thus verify-
ing the specificity of the interactions observed. These exper-
iments demonstrated that stonin 2 has the ability to interact
with Eps15, Eps15R, and intersectin 1 via the two NPF mo-
tifs in its proline-rich region.
In Vitro and In Vivo Interactions of Stonin 2 
with Eps15 and Intersectin 1
The interaction of stonin 2 with Eps15 was confirmed using
in vitro binding assays. An in vitro translated, [35S]methio-
nine-labeled construct comprising the proline-rich and stonin
homology domains of stonin 2 tagged with the Myc epitope
was found to bind to a GST fusion protein having the three
EH domains from Eps15, but not to GST (Fig. 4 B). Muta-
tion of either or both NPF motifs largely abolished binding.
This suggested that both NPF motifs are required for bind-
ing in vitro in apparent contradiction with the results of two-
hybrid analyses, which showed that the first NPF motif was
more important for interactions. This discrepancy could be
explained by the greater sensitivity of yeast two-hybrid as-
says to low-affinity interactions. Similar results were ob-
tained by transiently expressing the same stonin 2 constructs
in transfected HeLa cells rather than by in vitro translation
(Fig. 4 C). Furthermore, GST fused to the EH domains of
Eps15 or intersectin 1 were able to bind endogenous stonin
2, but not stonin 1, from a HeLa cell lysate (Fig. 4 D).
Next, we investigated if the endogenous stonin 2, and
Eps15 formed a complex in vivo. This was done by immu-
noprecipitation of HeLa cell lysates with either preim-
mune sera (PI) or antibodies to stonin 1 or stonin 2, and
then blotting for Eps15 (Fig. 5 A). In agreement with the
two-hybrid and in vitro binding assays, we could demon-
strate association of stonin 2, but not stonin 1, with Eps15
Figure 4. Interactions of stonin 2 (Stn2) with Eps15 and inter-
sectin 1 analyzed using the yeast two-hybrid system (A) and in
vitro binding assays (B–D). (A) GAL4 DNA binding domain
constructs encoding the three EH domains from Eps15 or the re-
lated Eps15R protein, the two EH domains from intersectin 1, or
mouse (m) p53 (as a specificity control) were coexpressed with
GAL4ad constructs encoding full-length stonin 1, full-length sto-
nin 2, the PRD   SHD domains of stonin 2 (Fig. 1 A) or various
mutants of this segment, epsin 2, or the SV40 T antigen (as a
specificity control). Interactions were tested by monitoring
growth on plates containing –His  Ade, –His –Ade, or  His
 Ade (control) media. (B) In vitro translated, [35S]methionine-
labeled PRD   SHD domains of stonin 2 tagged with the Myc
epitope and mutants of this construct were tested for interaction
with either a GST fusion protein bearing the three EH domains
of Eps15 or with GST using a conventional pull-down assay.
Fractions bound and not bound to the glutathione–Sepharose
beads are shown. (C) Similar to B, except that stonin 2 constructs
were expressed by transient transfection into HeLa cells, ex-
tracted with Triton X-100, and bound and unbound proteins de-
tected by immunoblotting with anti-Myc antibody. (D) A Triton
X-100 extract of [35S]methionine-labeled HeLa cells containing
endogenous stonin 1 and stonin 2 was incubated with GST or
GST fusion proteins bearing the three EH domains from Eps15
or the two EH domains from intersectin 1. Unbound and bound
stonin 1 and stonin 2 were isolated by immunoprecipitation–
recapture. The positions of molecular mass markers (in kD) are
indicated on the left of B–D.Martina et al. Stonins and Endocytosis 1117
in vivo. A similar experiment could not be performed for
intersectin 1 because the antibody to this protein did not
work well for immunoblotting. To circumvent this prob-
lem, we performed another experiment in which HeLa
cells were transfected with plasmids encoding either GFP
or GFP–stonin 2. Intersectin 1 was then isolated by immu-
noprecipitation, and the immunoprecipitates were ana-
lyzed by immunoblotting with antibody to GFP (Fig. 5 B).
Using this approach, we could demonstrate coprecipitation
of intersectin 1 with GFP–stonin 2, but not GFP (Fig. 5 B).
To map the structural determinants for Eps15–stonin 2
interactions in vivo, we transfected HeLa cells with con-
structs encoding stonin 1, stonin 2, or mutants of stonin 2
fused to GFP (Fig. 5 C). We then immunoprecipitated the
GFP fusion proteins and tested for the presence of Eps15
by immunoblotting. Again, we found that Eps15 coprecip-
itated with the stonin 2, but not stonin 1, fusion protein.
This in vivo interaction was mediated by the proline-rich
domain of stonin 2 and required the two NPF motifs
within this domain (Fig. 5 C). Since Eps15 has multiple
DPF motifs in its COOH-terminal region that bind to the
 -adaptin subunit of AP-2 (Benmerah et al., 1996), we also
tested for the presence of  -adaptin in the anti-GFP–stonin
immunoprecipitates. As expected, we found that  -adap-
tin was present only in the immunoprecipitates that con-
tained Eps15 (Fig. 5 C), suggesting that AP-2 is indirectly
associated with stonin 2 via Eps15.
Interaction of Stonin 2 with Synaptotagmins I and II
Despite the overall homology of the  -homology domain
of the stonins to the YXXØ-binding domain of AP–  sub-
units, residues involved in interactions of  2 with YXXØ
signals (Owen and Evans, 1998) (denoted by blue dots in
Fig. 1 C) are not conserved in the stonins. In line with this
observation, yeast two-hybrid assays revealed that neither
human stonin was able to bind a panel of 10 different
YXXØ signals (data not shown).  2 (Haucke et al., 2000)
as well as D. melanogaster stoned B (Phillips et al., 2000)
have been shown to bind to the C2B domain of synap-
totagmin I. We found that 4.9–6.5% of Myc–stonin 2 ex-
pressed by transient transfection into HeLa cells bound to
GST fusion proteins bearing the cytoplasmic domains of
synaptotagmins I and II (Fig. 6 A). This binding was
judged to be specific, as only a negligible amount of Myc–
stonin 2 was recovered on a GST–GGA3 fusion protein
(Fig. 6 A) or GST (data not shown). Additional GST pull-
down assays revealed that Myc–stonin 2 interacted mainly
with the C2B domain of both synaptotagmins (Fig. 6 B).
Overexpression of Stonin 2 Impairs 
Receptor-mediated Endocytosis
Although our antibodies to stonin 2 allowed us to immuno-
precipitate the endogenous protein, they were not sensi-
tive enough for immunofluorescence microscopy. This
prompted us to examine the localization of GFP–stonin 2
expressed by transfection into cells. We observed a hetero-
geneous distribution including dispersed punctate and jux-
tanuclear structures superimposed over a diffuse cytoplas-
mic pattern (Fig. 7, A, D, and G). Some of the punctate
structures colocalized with AP-2 (Fig. 7, M–O, inset). At
the highest expression levels, we observed a coalescence of
GFP–stonin 2 in the juxtanuclear area (Fig. 7 M). In these
cells, we noticed a depletion of AP-2 from plasma mem-
brane clathrin-coated pits and its colocalization with the
juxtanuclear GFP–stonin 2 (Fig. 7, N and O, arrow). This
behavior of stonin 2 was similar to that reported for epsin 2
(Rosenthal et al., 1999), consistent with the ability of both
proteins to interact directly or indirectly with AP-2. Over-
expression of GFP–stonin 2 had no effect on the distribu-
tion of two other AP complexes, AP-1 and AP-3 (data not
shown), indicating that the effects on AP-2 were specific.
The ability of stonin 2 to interact with several compo-
nents of the endocytic machinery predicted that overex-
pression of GFP–stonin 2 could interfere with receptor-
mediated endocytosis, as is the case for epsin 2 (Rosenthal
et al., 1999). Indeed, we observed that GFP–stonin 2 over-
expression inhibited internalization of Cy3-transferrin
(Fig. 7, A–C), rhodamine-EGF (D–F), and Dil-LDL (G–I)
by their corresponding receptors. Overexpression of GFP,
on the other hand, had no effect on internalization of Cy3-
transferrin (Fig. 7, J–L) or the other ligands (data not
shown). These observations further emphasize the func-
tional connection of stonin 2 to the endocytic machinery.
Figure 5. Interactions of stonin 2 with Eps15, AP-2, and inter-
sectin 1 in vivo. (A) Coprecipitation of endogenous stonin 2 with
Eps15. A Triton X-100 extract of HeLa cells was subjected to im-
munoprecipitation with preimmune sera (PI) or antibodies to
stonin 1 (Stn1) or stonin 2 (Stn2). The presence of coprecipitated
Eps15 was detected by immunoblotting. (B) Coprecipitation of
transfected GFP–stonin 2 with endogenous intersectin 1. The
GFP or GFP–stonin 2 constructs were expressed by transfection
into HeLa cells and isolated by immunoprecipitation with anti-
GFP or antiintersectin antibodies from Triton X-100 extracts of
the cells. The presence of the GFP proteins was revealed by im-
munoblotting using anti-GFP antibodies. (C) Coprecipitation of
endogenous Eps15 and AP-2 with transfected GFP–stonin con-
structs. The GFP–stonin fusion proteins indicated in the figure
were expressed by transfection into HeLa cells and isolated by
immunoprecipitation with anti-GFP antibodies from Triton X-100
extracts of the cells. The presence of Eps15 and the   subunit of
AP-2 were revealed by immunoblotting. The positions of molec-
ular mass markers (in kD) are indicated on the left. *Indicates
the heavy chains of anti-GFP antibody used in B and C.The Journal of Cell Biology, Volume 153, 2001 1118
Discussion
Here, we report the identification of two ubiquitous hu-
man proteins, stonin 1 and stonin 2, which have a modular
structure characteristic of components of the endocytic
machinery. In all of our protein interaction analyses, we
could only demonstrate weak binding of stonin 1 to synap-
totagmins I and II. Thus, at present we do not know if the
nature of the stonin 1 modules is indicative of a role in en-
docytosis or other protein sorting processes. We were
more successful, however, in identifying several proteins
that interact with stonin 2 (i.e., Eps15, Eps15R, intersectin
1, and synaptotagmins I and II). All of these interaction
partners have been previously implicated in endocytosis,
which makes it likely that stonin 2 is also a component of
the endocytic machinery. In support of this notion, overex-
pression of stonin 2 perturbs the localization of AP-2 to
the plasma membrane and inhibits internalization of sev-
eral endocytic receptors.
The proline-rich domain of stonin 2 contains two NPF
motifs that mediate interactions with the EH domains of
Eps15, Eps15R, and intersectin 1. This property is shared
with other NPF-containing endocytic proteins such as epsin
1 (Chen et al., 1998; Yamabhai et al., 1998), epsin 2 (Ya-
mabhai et al., 1998; Rosenthal et al., 1999), the 170-kD form
of synaptojanin (Haffner et al., 1997), nonneuronal mem-
bers of the AP180/CALM family (Dreyling et al., 1996;
Tebar et al., 1999), several SCAMP isoforms (Fernández-
Chacón et al., 2000), and Numb (Santolini et al., 2000). De-
spite the fact that all of these NPF-containing proteins
share the same EH-containing partners, interactions be-
tween them and Eps15 need not be competitive since Eps15
is a tetramer (Cupers et al., 1997; Tebar et al., 1997) and
could thus assemble simultaneously with several NPF-con-
taining proteins. The proline-rich domains of stonin 1 and
stonin 2 also contain several PxxP motifs that could poten-
tially interact with SH3 domains of endocytic proteins such
as intersectins, amphiphysins, and endophilins (for review
see Slepnev and De Camilli, 2000), or with other domains
that recognize proline-based motifs (Kay et al., 2000).
The  -homology domains of stonin 1 and stonin 2 are
likely to fold into an all  -sheet structure similar to that of
the YXXØ-binding domain of the  2 subunit of AP-2
(Owen and Evans, 1998). This similarity notwithstanding,
the human stonins do not appear to bind either tyrosine- or
dileucine-based endocytic signals in the yeast two-hybrid
system (data not shown). The possibility remains that they
could recognize a different type of signal. Nonetheless, the
stonins do share with  2 the ability to bind the C2B domain
of synaptotagmins I and II, most likely through a conserved
interface distinct from the YXXØ-binding site (Haucke et
al., 2000). Synaptotagmins have been proposed to function
as docking proteins for the AP-2 complex, in what would
constitute the first step in the assembly of clathrin coats onto
the plasma membrane (Zhang et al., 1994). By analogy, syn-
aptotagmins could also function to recruit stonin 2 to mem-
branes via C2B– -homology domain interactions. The NPF
motifs of stonin 2 would then serve as ligands for EH-con-
taining proteins such as Eps15, Eps15R, and intersectin 1.
These proteins would, in turn, congregate all of their other
binding partners (e.g., epsins, dynamins, synaptojanins, en-
dophilins, and syndapins) at the membrane, and assembly of
a clathrin coat and vesicle formation would ensue.
The AP-2 complex is similarly able to bind to synap-
totagmin I via its   and  2 subunits (Zhang et al., 1994;
Haucke et al., 2000) and to Eps15 and Eps15R via its   sub-
unit (Benmerah et al., 1996; Salcini et al., 1999). It is thus
plausible that the role of stonin 2 could be partly redundant
or alternative to that of AP-2. Another possibility is that
stonin 2 and AP-2 cooperate to stabilize the dynamic net-
work of low-affinity interactions required to assemble a
functional endocytic coat. The coprecipitation of endoge-
nous AP-2 with stonin 2, which is likely mediated by Eps15
(Fig. 5), argues in favor of the latter explanation. The fact
that mutations in either the   subunit of AP-2 (Dornan et
al., 1997; González-Gaitán and Jackle, 1997) or stoned B
(Andrews et al., 1996; Fergestad et al., 1999) in D. melano-
gaster result in defective synaptic vesicle recycling further
suggests that both AP-2 and stoned B (of which stonin 2
appears to be the most closely related human homologue)
play unique and essential roles in endocytosis.
In addition to providing additional linking potential to
the assembling coats, stonin 2 could be involved in the se-
lection of specific cargo molecules for incorporation into
the budding vesicles. In favor of this hypothesis is the ob-
servation that synaptotagmin is mislocalized in D. melano-
Figure 6. Stonin 2 binds to
synaptotagmins I and II. (A)
Interaction of stonin 2 with the
cytoplasmic (C2AB) domains
of synaptotagmins I and II.
Triton X-100 extracts of HeLa
cells, transiently expressing
Myc-Stn2 or from untrans-
fected cells, were incubated
with GST fusion proteins
comprising the C2A and C2B
domains of synaptotagmins I
or II, or with GST–GGA3GAE
(specificity control), using a
conventional pull-down assay.
(B) Interaction of stonin 2 with the C2B domain of synaptotagmins I and II. Similar to A, except that the cell extracts were incubated
with GST fusion proteins comprising the C2A or C2B domains of synaptotagmins I and II. The presence of Myc-Stn2 in the bound mate-
rial was revealed by immunoblotting (IB) using monoclonal antibodies to the Myc epitope. Coomassie blue staining of the gels revealed
that similar amounts of GST fusion proteins were used.Martina et al. Stonins and Endocytosis 1119
gaster stoned mutants (Fergestad et al., 1999). Moreover,
synaptotagmin appears to be degraded more rapidly in
stoned mutants (Fergestad et al., 1999). In contrast, the lo-
calization and stability of other synaptic vesicle proteins
are unaltered in stoned mutants (Fergestad et al., 1999).
These observations suggest that stoned B could play a role
in the specific retrieval of a subset of synaptic vesicle pro-
teins including synaptotagmin. The dual roles of stonin 2
and stoned B in coat assembly and cargo selection need
not be mutually exclusive, as the AP-2 complex is known
to participate in both processes.
The neurological defects of D. melanogaster stoned mu-
tants are likely due to perturbation of the high endocytic
activity of presynaptic terminals. Although less obvious,
other endocytic processes in stonin-deficient organisms
may be defective as well. The expression of stonin 2 in
most human tissues and cells examined, its ability to inter-
act with several widely-expressed proteins, and the over-
Figure 7. Effects of over-
expression of GFP–stonin 2
on Cy3-Tf, rhodamine-EGF
(Rhod-EGF), Dil-LDL in-
ternalization, and AP-2 lo-
calization. HeLa cells were
transfected with plasmids en-
coding either GFP–stonin 2
(A–I and M–O) or GFP
alone (J–L). Live cells were
incubated for 15 min in the
presence of Cy3-Tf (A–C and
J–L), rhodamine-EGF (D–F)
or Dil-LDL (G–I) at 37 C.
AP-2 (M–O) was detected by
immunofluorescence micros-
copy using antibodies to
 -adaptin (AP.6) followed by
Cy3-conjugated donkey anti–
mouse IgG. Cells were exam-
ined by confocal fluorescence
microscopy. (A, D, G, J, and
M) GFP fluorescence
(green); (B and K) Cy3-Tf
(red); (E) Rhodamine-EGF
(red); (H) Dil-LDL (red);
(N) AP-2 (red). Arrow
points to transfected cell ex-
hibiting accumulation of
AP-2 in the juxtanuclear
area. Bars, 10  m.The Journal of Cell Biology, Volume 153, 2001 1120
expression-induced interference with receptor-mediated
endocytosis in nonneuronal cells, all suggest that stonin 2
may play a general role in endocytosis.
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